| |
| Issue |
Title |
| |
| Vol 15, No 6 (2025) |
Aetiopathogenetic Architecture for Pharmaceutical Development (Using Gout as a Case Study) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. V. Avdeeva, N. R. Varina, T. K. Ryazanova, V. A. Kurkin, N. V. Isakova, L. T. Volova, D. A. Poltoretskii |
| |
| Vol 15, No 4 (2025) |
Strategic Indicators in the Development of Original Medicinal Products in 2024: Analysis of Pipelines of International Pharmaceutical Leaders |
Abstract
PDF (Rus)
PDF (Eng)
|
|
L. S. Litvin, E. A. Kulikova |
| |
| No 1 (2016) |
New opportunities for the determination of active substances in organic compounds |
Abstract
PDF (Rus)
|
|
L. I. Mitkina |
| |
| No 1 (2016) |
Shared knowledge centre (research and education centre) of the Peoples’ Friendship University of Russia as a modern experimental basis for the development of drug standards |
Abstract
PDF (Rus)
|
|
R. A. Abramovich, O. G. Potanina, V. V. Chistyakov, S. V. Goryainov, A. N. Vorobiev, A. V. Nikulin |
| |
| No 1 (2016) |
Optical methods in the study of drug chiral proporties. I. Valine in aqueous solutions with different deuterium content |
Abstract
PDF (Rus)
|
|
A. V. Syroeshkin, T. V. Pleteneva, E. V. Uspenskaya, O. V. Levitskaya |
| |
| No 4 (2016) |
Biological mechanisms of natural cytoprotection - a promising trend in the development of new medicines aimed at prevention and treatment of preeclampsia |
Abstract
PDF (Rus)
|
|
M. V. Pokrovsky, V. V. Gureev, E. G. Stupakova, O. E. Antsiferova, T. I. Lokteva, L. A. Zhilinkova |
| |
| 1 - 6 of 6 Items |
|
